Results 271 to 280 of about 462,118 (388)

Angiotensin-converting enzyme in innate and adaptive immunity

open access: yesNature Reviews Nephrology, 2018
K. Bernstein   +5 more
semanticscholar   +1 more source

Lower left ventricular ejection time in MYBPC3 variant carriers with overt or subclinical hypertrophic cardiomyopathy

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Hypertrophic cardiomyopathy (HCM) is an inherited cardiomyopathy often caused by pathogenic variants in MYBPC3 and MYH7, encoding myosin‐binding protein C3 and myosin heavy chain 7, respectively. These variants can cause increased actin–myosin crossbridge cycling, resulting in ventricular hypercontractility, but mice lacking Mybpc3 ...
Isabell Yan   +10 more
wiley   +1 more source

The isolation of angiotensin-converting enzyme cDNA.

open access: hybrid, 1988
Kenneth E. Bernstein   +5 more
openalex   +1 more source

Clinical impact of follow‐up endomyocardial biopsy in myocarditis during or after immune‐suppressive therapy

open access: yesESC Heart Failure, EarlyView.
Results and clinical implication of repeat endomyocardial biopsy (EMB). Abstract Aims While the diagnostic role of endomyocardial biopsy (EMB) in myocarditis is unquestioned, little is known about its indications and clinical value during long‐term follow‐up.
Anna Baritussio   +12 more
wiley   +1 more source

A promise to save 100,000 trauma patients.

open access: yes, 2013
Horton, Richard   +5 more
core   +1 more source

Analysis of outcomes in patients with HeartMate 3 with and without right ventricular assist device support

open access: yesESC Heart Failure, EarlyView.
Temporary RVAD support following HM3 LVAD is associated with high morbidity and mortality. Temporary RVAD support occurs most frequently in INTERMACS 1 or 2 patients and those who require pre‐operative VA‐ECMO. In addition to higher post‐operative mortality, a significantly higher risk of both dialysis and stroke at 1 year post‐implant was observed in ...
Vinh Q. Chau   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy